1887

Abstract

Summary

The subtype of verotoxin 2 (VT2) found in 22 VT2-positive stool samples from severely diseased Italian and German children with haemorrhagic colitis or haemolytic uraemic syndrome, or both, and that produced by the corresponding VT-producing (VTEC) strains isolated from the stools were studied by cytotoxicity sero-neutralisation assays and by polymerase chain reaction (PCR) amplification of the VT2 B-subunit gene, followed by restriction fragment length polymorphism (RFLP) analysis. The free faecal toxin was serotyped as the classical VT2 in 21 stool samples, and as the VT2 variant VT2c in one. For all but one of the VTEC isolates, the toxin phenotype was consistent with the type of VT produced and found in the corresponding stool samples. Genotyping was in agreement with phenotyping for those strains harbouring a single type of VT2 gene. Three O157: H7 isolates carrying both VT2 and VT2c genes had the VT2 phenotype, instead of the expected VT2c phenotype. Direct PCR analysis of stools detected VT genes in only 11 of 20 VT-positive stool samples suggesting that the Vero cell cytotoxicity assay is more sensitive in diagnosing VTEC infection. Immunological and genetic subtyping of VT2 performed directly on stool samples from patients with haemolytic uraemic syndrome could be a useful complementary approach to understanding the role of the different types of VT in this syndrome.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-43-5-348
1995-11-01
2022-10-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/43/5/medmicro-43-5-348.html?itemId=/content/journal/jmm/10.1099/00222615-43-5-348&mimeType=html&fmt=ahah

References

  1. Karmali M. A. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989; 2:15–38
    [Google Scholar]
  2. Griffin P. M., Tauxe R. V. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13:60–98
    [Google Scholar]
  3. O’Brien A. D., Holmes R. K. Shiga and Shiga-like toxins. Microbiol Rev 1987; 51:206–220
    [Google Scholar]
  4. Strockbine N. A., Marques L. R. M., Newland J. W., Smith H. W., Holmes R. K., O’Brien A. D. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 1986; 53:135–140
    [Google Scholar]
  5. Samuel J. E., Perera L. P., Ward S., O’Brien A. D., Ginsburg V., Krivan H. C. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun 1990; 58:611–618
    [Google Scholar]
  6. Tyler S. D., Johnson W. M., Lior H., Wang G., Rozee K. R. Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol 1991; 29:1339–1343
    [Google Scholar]
  7. Schmitt C. K., McKee M. L., O’Brien A. D. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H—strain E32511. Infect Immun 1991; 59:1065–1073
    [Google Scholar]
  8. O’Brien A. D., Karmali M. A., Scotland S. M. A proposal for rationalizing the nomenclature of the Escherichia coli cytotoxins. In Karmali M. A., Goglio A. G. (eds) Recent advances in Verocytotoxin-producing Escherichia coli infections Amsterdam: Elsevier Science BV; 1994147–149
    [Google Scholar]
  9. Hii J. H., Gyles C., Morooka T. Development of verotoxin 2-and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1. J Clin Microbiol 1991; 29:2704–2709
    [Google Scholar]
  10. Gunzer F., Böhm H., Rüssmann H., Bitzan M., Aleksic S., Karch H. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J Clin Microbiol 1992; 30:1807–1810
    [Google Scholar]
  11. Thomas A., Smith H. R., Rowe B. Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate vero cytotoxin-producing Escherichia coli strains of serogroup O157. J Clin Microbiol 1993; 31:1700–1703
    [Google Scholar]
  12. Rüssmann H., Schmidt H., Heesemann J., Caprioli A., Karch H. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J Med Microbiol 1994; 40:338–343
    [Google Scholar]
  13. Caprioli A., Luzzi I., Rosmini F. Hemolytic-uremic syndrome and verocytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group. J Infect Dis 1992; 166:154–158
    [Google Scholar]
  14. Gianviti A., Rosmini F., Caprioli A. Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Pediatr Nephrol 1994; 8:705–709
    [Google Scholar]
  15. Bitzan M., Moebius E., Ludwig K., Müller-Wiefel D. E., Heesemann J., Karch H. High incidence of serum antibodies to Escherichia coli 0157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr 1991; 119:380–385
    [Google Scholar]
  16. Karch H., Meyer T. Evaluation of oligonucleotide probes for identification of Shiga-like-toxin-producing Escherichia coli. J Clin Microbiol 1989; 27:1180–1186
    [Google Scholar]
  17. Luzzi I., Minelli F., Gianviti A., Caprioli A. Impaired detection of faecal verocytotoxin in the presence of Clostridium difficile cytotoxin in patients with haemolytic uraemic syndrome. Eur J Clin Microbiol Infect Dis 1992; 11:934–936
    [Google Scholar]
  18. Caprioli A., Luzzi I., Rosmini F. Communitywide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis 1994; 169:208–211
    [Google Scholar]
  19. Brian M. J., Frosolono M., Murray B. E. Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome. J Clin Microbiol 1992; 30:1801–1806
    [Google Scholar]
  20. Ostroff S. M., Tarr P. I., Neill M. A., Lewis J. H., Hargrett-Bean N., Kobayashi J. M. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 1989; 160:994–998
    [Google Scholar]
  21. Chart H., Smith H. R., Scotland S. M., Rowe B., Milford D. V., Taylor C. M. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 1991; 337:138–140
    [Google Scholar]
  22. Kleanthous H., Smith H. R., Scotland S. M. Haemolytic uraemic syndromes in the British Isles, 1985–8: association with Verocytotoxin producing Escherichia coli. Part 2: microbiological aspects. Arch Dis Child 1990; 65:722–727
    [Google Scholar]
  23. Thomas A., Cheasty T., Chart H., Rowe B. Isolation of Verocytotoxin-producing Escherichia coli serotypes O9ab:H— and O101:H— carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome. Eur J Clin Microbiol Infect Dis 1994; 13:1074–1076
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-43-5-348
Loading
/content/journal/jmm/10.1099/00222615-43-5-348
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error